These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3995687)

  • 1. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
    Sommer HH; Fosså SD; Lien HH
    Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative and adjuvant chemotherapy of metastatic renal cancer.
    Kühböck J; Pötzi P; Madaras T
    Semin Surg Oncol; 1988; 4(2):116-23. PubMed ID: 2455928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
    Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
    Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
    Bergerat JP; Herbrecht R; Dufour P; Jacqmin D; Bollack C; Prevot G; Bailly G; de Garis S; Juraschek F; Oberling F
    Cancer; 1988 Dec; 62(11):2320-4. PubMed ID: 3141036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined interferon and vinblastine treatment in advanced renal cell cancer.
    Kellokumpu-Lehtinen P; Jantunen I; Flander M; Johansson R; Nordman E
    Acta Oncol; 1995; 34(7):975-7. PubMed ID: 7492395
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomas.
    Presant CA; Kennedy P; Wiseman C; Gala K; Smith JD; Bouzaglou A; Farbstein M; Multhauf P; Bertrand M; Green L
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):329-30. PubMed ID: 3709601
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
    Braybrooke JP; Vallis KA; Houlbrook S; Rockett H; Ellmén J; Anttila M; Ganesan TS; Harris AL; Talbot DC
    Cancer Chemother Pharmacol; 2000; 46(1):27-34. PubMed ID: 10912574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of vinblastine and doxorubicin in advanced renal cell carcinoma.
    Jekunen A; Stengård J; Pyrhönen S
    Eur J Cancer; 1994; 30A(2):245. PubMed ID: 8155397
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic renal cell cancer treated with recombinant alpha 2a interferon and vinblastine.
    Massidda B; Migliari R; Padovani A; Scarpa RM; Pellegrini P; Cortesi E; Usai E; Pellegrini A
    J Chemother; 1991 Dec; 3(6):387-9. PubMed ID: 1819623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.
    Small EJ; Frye JW; Wilkinson MJ; Carroll PR; Ernest ML; Stagg RJ
    Cancer; 1994 Jun; 73(11):2803-7. PubMed ID: 8194022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.
    Liu JH; Yang MH; Fan FS; Yen CC; Wang WS; Chang YH; Chen KK; Chen PM
    Urology; 2001 Apr; 57(4):650-4. PubMed ID: 11306370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
    Haas NB; Giantonio BJ; Litwin S; Minniti CJ; Fox S; Yeslow G; Reilly R; Nahum K; Greenberg R; Halbherr T; Hudes GR
    Cancer; 2003 Nov; 98(9):1837-41. PubMed ID: 14584064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
    Hahn RG; Begg CB; Davis T
    Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB).
    Sorio R; Galligioni E; Crivellari D; Talamini R; Monfardini S
    Ann Oncol; 1995 Mar; 6(3):306-7. PubMed ID: 7612500
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinoma.
    Trump DL; Ravdin PM; Borden EC; Magers CF; Whisnant JK
    J Biol Response Mod; 1990 Feb; 9(1):108-11. PubMed ID: 2319258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon plus vinblastine in renal carcinoma patients who had failed on interferon alone.
    Merimsky O; Chaitchik S
    Eur J Cancer; 1990; 26(8):921. PubMed ID: 2145941
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma.
    Tai CJ
    Acta Oncol; 2009; 48(6):931-2. PubMed ID: 19925379
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
    Schwartsmann G; Medina de Cunha F; Silveira LA; Salgado G; Thereza MS; Vinholes J; Preger P; Segal F
    Ann Oncol; 1991 Jun; 2(6):443. PubMed ID: 1768632
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.